Dib Bustros Youssef, Fechtner Robert, S Khouri Albert
Resident, Department of Ophthalmology, Saint George Hospital University Medical Center, Beirut, Lebanon.
Professor and Chairman, Department of Ophthalmology, SUNY Upstate Medical University, Syracuse, New York, USA.
J Curr Glaucoma Pract. 2017 May-Aug;11(2):42-47. doi: 10.5005/jp-journals-10028-1221. Epub 2017 Aug 5.
To compare the efficacy and safety of Ex-PRESS glaucoma filtration surgery to trabeculectomy in African origin patients.
A retrospective chart review was performed on 56 African American patients undergoing Ex-PRESS glaucoma shunt (E) or trabeculectomy (T) between 2004 and 2012. Data collected included intraocular pressure (IOP) and glaucoma medication use at baseline and postoperative week 1, Month (M) 1, M3, M6, M12. Postoperative interventions including laser suture lysis (LSL) and 5FU injections were analyzed. Complete and qualified success rate, and eyes failing and requiring more surgery were determined. Means, SD, chi-square, and Student's t-test were performed.
A total of 56 subjects (E 28, T 28) were included in the analysis. There was a statistically significant reduction (p < 0.05) in IOP and number of glaucoma medications at all time points compared to baseline for both groups. Extent of IOP reduction between groups was not statistically significant at any time point, except postoperative week 1. Mean number of glaucoma medications between groups was not significant, except at 3 months (lower in EXP group). The cumulative number of postoperative interventions within 3 months (LSL and 5-FU) was significantly greater for the TRAB than EXP (3.89 ± 2.4 2.36 ± 2.2, p = 0.007). Success rates were comparable between both groups (Table 2).
Our study is unique in patients of African origin showing statistical significance in the requirement of less postoperative 5-FU injections during the first 3 months following surgery in the Ex-PRESS group the trabeculectomy group. The Ex-PRESS shunt was as effective as trabeculectomy in reducing IOP and use of glaucoma medications up to 1 year.
The possible benefit of this article is to help guiding ophthalmologists to select the type of glaucoma filtration surgery to undergo in an African American patient with glaucoma.
Bustros YD, Fechtner R, Khouri AS. Outcomes of Ex-PRESS and Trabeculectomy in a Glaucoma Population of African Origin: One Year Results. J Curr Glaucoma Pract 2017;11(2):42-47.
比较Ex-PRESS青光眼滤过手术与小梁切除术在非洲裔患者中的疗效和安全性。
对2004年至2012年间接受Ex-PRESS青光眼分流术(E组)或小梁切除术(T组)的56例非裔美国患者进行回顾性病历审查。收集的数据包括基线时以及术后第1周、1个月(M1)、3个月(M3)、6个月(M6)、12个月(M12)时的眼压(IOP)和青光眼药物使用情况。分析术后干预措施,包括激光缝线松解术(LSL)和5-氟尿嘧啶(5FU)注射。确定完全成功率、合格成功率以及手术失败且需要进一步手术的眼数。进行均值、标准差、卡方检验和学生t检验。
共有56名受试者(E组28例,T组28例)纳入分析。与基线相比,两组在所有时间点的眼压和青光眼药物使用数量均有统计学显著降低(p<0.05)。除术后第1周外,两组间眼压降低程度在任何时间点均无统计学显著差异。除3个月时(EXP组较低)外,两组间青光眼药物平均使用数量无显著差异。小梁切除术组术后3个月内(LSL和5-FU)的术后干预累计次数显著多于Ex-PRESS组(3.89±2.4比2.36±2.2,p = 0.007)。两组成功率相当(表2)。
我们的研究在非洲裔患者中具有独特性,结果显示Ex-PRESS组在术后前3个月所需的5-FU注射次数少于小梁切除术组,具有统计学显著性。Ex-PRESS分流术在降低眼压和减少青光眼药物使用方面与小梁切除术在长达1年的时间内效果相当。
本文的可能益处在于帮助指导眼科医生为患有青光眼的非裔美国患者选择青光眼滤过手术的类型。
Bustros YD, Fechtner R, Khouri AS.非洲裔青光眼患者Ex-PRESS和小梁切除术的结果:一年结果。《当代青光眼实践杂志》2017;11(2):42 - 47。